Dr. Ann Sheehy recently weighed in on the clinical potential of FDA-approved self-collection HPV testing in the Annals of Internal Medicine, advocating for broader physician-led screening strategies.
Simultaneously, Ann Sheehy appeared on Science Vs to dissect the transmission risks of the Andes virus. Host Wendy Zukerman leaned on expert analysis to clarify that despite high exposure risks in regions like New Mexico, actual diagnosis rates remain low. “Anne, our virologist, told us that there might be something else working in our favor here too,” Zukerman noted, framing the data as a counterweight to the fear surrounding cruise ship outbreaks.
While the Science Vs episode focuses on the rarity of transmission, the broader conversation around Ann Sheehy’s work at the Health Resources and Services Administration suggests a shift toward patient-centered diagnostic autonomy. Expect more scrutiny on how her regulatory guidance impacts public uptake of self-testing kits as the year progresses.
